QA: Transcode Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001829635_2025_Transcode_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001829635, Transcode Therapeutics Inc

  xvar xval
0 AssetsCurrent 7,093,338
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 51,574
3 remainder_Assets 149,587
4 LiabilitiesCurrent 2,771,836
5 LiabilitiesNoncurrent 6,541,397
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,399,629
9 ResearchAndDevelopmentExpense 7,634,649
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -615,062
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,294,499
1 Liabilities 9,313,233
2 Expenses 13,034,278
3 Revenues 0
4 StockholdersEquity -2,018,734
5 NetIncome -13,649,340
6 ComprehensiveNetIncome -13,649,340
7 BaseVar 15,128,536
8 EconomicCapitalRatiobeforeLimitedLiability -2.17
9 EconomicCapitalRatio 0.966

Edgar->Model Mapping

Feature Distribution

Change over Time